Journal of Experimental Medicine, Vol 176, 449-457, Copyright © 1992 by Rockefeller University Press

ARTICLES

Cytotoxic T lymphocytes (CTL) against a transforming gene product select for transformed cells with point mutations within sequences encoding CTL recognition epitopes

NL Lill, MJ Tevethia, WG Hendrickson and SS Tevethia
Department of Microbiology and Immunology, Pennsylvania State University College of Medicine, Hershey 17033.

The 94-kD large tumor (T) antigen specified by simian virus 40 (SV40) is sufficient to induce cell transformation. T antigen contains four H- 2Db-restricted cytotoxic T lymphocyte (CTL) recognition epitopes that are targets for CTL clones Y-1, Y-2, Y-3, and Y-5. These epitopes have been mapped to T antigen amino acids 207-215 (site I), 223-231 (sites II and III), and 489-497 (site V), respectively. Antigenic site loss variant cells that had lost one or more CTL recognition epitopes were previously selected by coculturing SV40-transformed H-2Db cells with the site-specific Db-restricted CTL clones. The genetic bases for T antigen CTL recognition epitope loss from the variant cells were identified by DNA amplification and direct sequencing of epitope-coding regions from variant cell DNAs. Cells selected for resistance to CTL clone Y-1 (K-1; K-1,4,5; K-3,1) carry deleted SV40 genomes lacking site I, II, and III coding sequences. Point mutations present within the site II/III coding region of Y-2-/Y-3-resistant cell lines specify the substitution of asparagine for lysine as T antigen amino acid 228 (K-2) or phenylalanine for tyrosine at position 230 (K-3). Point mutations identified within independently selected Y-5 resistant populations (K-5 and K-1,4,5) direct the substitution of isoleucine for asparagine at position 496 (K-5) or the substitution of phenylalanine for isoleucine at position 491 (K-1,4,5) of T antigen. Each substitution causes loss of the relevant CTL recognition epitope, apparently by compromising CTL T cell receptor recognition. These experiments identify specific amino acid changes within a transforming protein that facilitate transformed cell escape from site-specific CTL clones while allowing maintenance of cellular transformation. This experimental model system provides unique opportunities for studying mechanisms of transformed cell escape from active immunosurveillance in vivo, and for analysis of differential host immune responses to wild-type and mutant cell-transforming proteins.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Iannello, A., Debbeche, O., Martin, E., Attalah, L. H., Samarani, S., Ahmad, A. (2006). Viral strategies for evading antiviral cellular immune responses of the host. J. Leukoc. Biol. 79: 16-35 [Abstract] [Full Text]  
• Otahal, P., Hutchinson, S. C., Mylin, L. M., Tevethia, M. J., Tevethia, S. S., Schell, T. D. (2005). Inefficient Cross-Presentation Limits the CD8+ T Cell Response to a Subdominant Tumor Antigen Epitope. J. Immunol. 175: 700-712 [Abstract] [Full Text]  
• Schell, T. D. (2004). In Vivo Expansion of the Residual Tumor Antigen-Specific CD8+ T Lymphocytes That Survive Negative Selection in Simian Virus 40 T-Antigen-Transgenic Mice. J. Virol. 78: 1751-1762 [Abstract] [Full Text]  
• Matsui, K., O'Mara, L. A., Allen, P. M. (2003). Successful elimination of large established tumors and avoidance of antigen-loss variants by aggressive adoptive T cell immunotherapy. Int Immunol 15: 797-805 [Abstract] [Full Text]  
• Akilesh, S., Dudley, M. E., Eden, P. A., Roopenian, D. C. (2001). Efficient Chromosomal Mapping of a Methylcholanthrene- Induced Tumor Antigen by CTL Immunoselection. J. Immunol. 167: 5143-5149 [Abstract] [Full Text]  
• Schell, T. D., Knowles, B. B., Tevethia, S. S. (2000). Sequential Loss of Cytotoxic T Lymphocyte Responses to Simian Virus 40 Large T Antigen Epitopes in T Antigen Transgenic Mice Developing Osteosarcomas. Cancer Res. 60: 3002-3012 [Abstract] [Full Text]  
• Schell, T. D., Mylin, L. M., Georgoff, I., Teresky, A. K., Levine, A. J., Tevethia, S. S. (1999). Cytotoxic T-Lymphocyte Epitope Immunodominance in the Control of Choroid Plexus Tumors in Simian Virus 40 Large T Antigen Transgenic Mice. J. Virol. 73: 5981-5993 [Abstract] [Full Text]  
• Mylin, L. M. (1999). Context-Dependent Immunogenicity of an S206G-Substituted H-2Db-Restricted Simian Virus 40 Large T Antigen Epitope I Variant. J. Immunol. 162: 2171-2179 [Abstract] [Full Text]  
• Mortara, L., Letourneur, F., Gras-masse, H., Venet, A., Guillet, J.-G., Bourgault-Villada, I. (1998). Selection of Virus Variants and Emergence of Virus Escape Mutants after Immunization with an Epitope Vaccine. J. Virol. 72: 1403-1410 [Abstract] [Full Text]  
• Fu, T.-M., Mylin, L. M., Schell, T. D., Bacik, I., Russ, G., Yewdell, J. W., Bennink, J. R., Tevethia, S. S. (1998). An Endoplasmic Reticulum-Targeting Signal Sequence Enhances the Immunogenicity of an Immunorecessive Simian Virus 40 Large T Antigen Cytotoxic T-Lymphocyte Epitope. J. Virol. 72: 1469-1481 [Abstract] [Full Text]  
• Toes, R. E. M., Hoeben, R. C., van der Voort, E. I. H., Ressing, M. E., van der Eb, A. J., Melief, C. J. M., Offringa, R. (1997). Protective anti-tumor immunity induced by vaccination with recombinant adenoviruses encoding multiple tumor-associated cytotoxic T lymphocyte epitopes in a string-of-beads fashion. Proc. Natl. Acad. Sci. USA 94: 14660-14665 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS